Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
about
Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and MetastasisTargeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?Cancer stem cells as therapeutic targets of hepato-biliary-pancreatic cancers.Interaction between NFATc2 and the transcription factor Sp1 in pancreatic carcinoma cells PaTu 8988t.Cellular and molecular aspects of pancreatic cancer.Proteasome activity is required for the initiation of precancerous pancreatic lesions.Precision medicine based on surgical oncology in the era of genome-scale analysis and genome editing technology.
P2860
Q27332168-442FDCDB-C95D-481F-AD87-F897DD6D412AQ33361738-E48E481B-439F-4FCB-BD65-7502BCC6459CQ38421310-E2EAB548-4E86-40DA-A0E9-7BE27650B170Q38647255-FAC6BDB3-D393-4A17-BDA3-6F47D82FFB75Q38730160-C7E6E3F7-5EB4-480E-B037-C62CD41090DBQ42750201-3D06BCD7-7F50-41E5-B687-EE852744D661Q55033899-DDDDAFE0-43F5-484E-96C4-65834F047908
P2860
Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
@en
type
label
Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
@en
prefLabel
Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
@en
P2860
P1476
Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
@en
P2093
Shinji Tanaka
P2860
P2888
P304
P356
10.1245/S10434-015-4463-X
P478
23 Suppl 2
P577
2015-03-07T00:00:00Z
P6179
1046007770